FDA Adverse Event Injury Summary report: N

RENAL - DISPOSABLE

MDR report key: 1905040 · Received November 22, 2010

Report

Report Number
1423500-2010-05997
Event Type
Injury
Date Received
November 22, 2010
Date of Event
October 1, 2010
Report Date
October 27, 2010
Product Code
KDJ
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TU
Reporter Occupation
NURSE

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THE DEVICES INVOLVED IN THE INCIDENT WERE UNKNOWN. AS THE DATE OF ONSET OF THIS PERITONITIS EPISODE IS UNKNOWN AND PATIENTS DISCARD SUPPLIES AFTER EACH THERAPY, THE SAMPLE WAS NOT REQUESTED. A 510(K) NUMBER WILL NOT BE PROVIDED IN THE EMDR AS THE PRODUCT CODE AND LOT NUMBER ARE UNKNOWN. SINCE THE LOT NUMBER IS UNKNOWN, NO BATCH REVIEW WILL BE PERFORMED. BAXTER HAS RECEIVED SIMILAR REPORTS FOR THE REPORTED PROBLEM. BAXTER WILL CONTINUE TO MONITOR SIMILAR REPORTS TO DETERMINE IF FURTHER ACTION IS REQUIRED.

Description of Event or Problem · 1

THIS IS A SPONTANEOUS REPORT BY A NURSE FROM (B)(6) OF CHEMICAL PERITONITIS IN A PATIENT COINCIDENT WITH PERITONEAL DIALYSIS (PD) THERAPY. ON (B)(6) 2010, THE PATIENT EXPERIENCED CHEMICAL PERITONITIS, MANIFESTED BY ABDOMINAL PAIN AND BLURRY PERITONEAL EFFLUENT. NO REMEDIAL TREATMENT WAS GIVEN TO THE PATIENT. PER THE REPORTER, THE BLURRY PERITONEAL EFFLUENT HAD BEEN CONFIRMED AND THE SOLUTION HAD BEEN CHANGED. ON (B)(6) 2010, EXTRANEAL THERAPY WITH LOT# M1008015 WAS DISCONTINUED. ON AN UNREPORTED DATE IN (B)(6) 2010, THE PATIENT RECOVERED FROM THE EVENT OF CHEMICAL PERITONITIS. IT WAS UNKNOWN WHETHER THE PATIENT CONTINUED THERAPY WITH A DIFFERENT LOT OF EXTRANEAL. THE REPORTER BELIEVED THE EVENT OF CHEMICAL PERITONITIS WAS RELATED TO EXTRANEAL THERAPY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RENAL - DISPOSABLE SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ

Patients

Seq Age Sex Outcome Treatment
1 48 YR Other EXTRANEAL VIAFLEX, ORAL CARDURA (ALFA 1-BLOCKER)| ORAL BEMIKS (VITAMIN B COMBINATION)| INTRAVENOUS MIRCERA (M.P.G. - EPOETIN BETA)